NWF Advisory Services Inc. Takes $906,000 Position in Tempus AI, Inc. $TEM

NWF Advisory Services Inc. purchased a new position in shares of Tempus AI, Inc. (NASDAQ:TEM) in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 11,229 shares of the company’s stock, valued at approximately $906,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. AQR Capital Management LLC bought a new position in Tempus AI during the second quarter worth about $54,020,000. Geode Capital Management LLC lifted its stake in shares of Tempus AI by 411.4% during the 2nd quarter. Geode Capital Management LLC now owns 649,420 shares of the company’s stock valued at $41,264,000 after buying an additional 522,443 shares in the last quarter. Marex Group plc purchased a new stake in shares of Tempus AI during the 2nd quarter valued at approximately $26,620,000. Gilder Gagnon Howe & Co. LLC boosted its holdings in Tempus AI by 1,747.6% in the 2nd quarter. Gilder Gagnon Howe & Co. LLC now owns 413,081 shares of the company’s stock worth $26,247,000 after buying an additional 390,723 shares during the period. Finally, Patient Capital Management LLC purchased a new position in Tempus AI in the 2nd quarter valued at approximately $24,693,000. 24.22% of the stock is currently owned by institutional investors.

Tempus AI Price Performance

Tempus AI stock opened at $66.81 on Wednesday. Tempus AI, Inc. has a 52 week low of $36.22 and a 52 week high of $104.32. The business has a 50-day simple moving average of $68.90 and a 200 day simple moving average of $74.02. The company has a quick ratio of 3.12, a current ratio of 3.28 and a debt-to-equity ratio of 2.45. The stock has a market cap of $11.89 billion, a price-to-earnings ratio of -56.14 and a beta of 5.22.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.05. The firm had revenue of $334.21 million during the quarter, compared to the consensus estimate of $328.89 million. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The company’s revenue for the quarter was up 84.7% on a year-over-year basis. During the same quarter last year, the company posted ($0.46) EPS. On average, research analysts forecast that Tempus AI, Inc. will post -6.15 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have issued reports on TEM shares. JPMorgan Chase & Co. dropped their target price on Tempus AI from $85.00 to $80.00 and set a “neutral” rating on the stock in a research report on Monday, December 15th. Canaccord Genuity Group decreased their price objective on Tempus AI from $95.00 to $80.00 and set a “buy” rating on the stock in a research note on Monday, December 22nd. HC Wainwright cut their target price on Tempus AI from $98.00 to $89.00 and set a “buy” rating for the company in a research note on Friday, November 7th. Needham & Company LLC upped their price target on Tempus AI from $70.00 to $100.00 and gave the company a “buy” rating in a research report on Wednesday, November 5th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of Tempus AI in a report on Thursday, January 22nd. Six equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $87.20.

Insider Activity at Tempus AI

In other news, CFO James William Rogers sold 19,966 shares of the firm’s stock in a transaction on Thursday, December 11th. The shares were sold at an average price of $73.20, for a total transaction of $1,461,511.20. Following the sale, the chief financial officer owned 111,250 shares in the company, valued at approximately $8,143,500. This trade represents a 15.22% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Eric P. Lefkofsky sold 166,250 shares of Tempus AI stock in a transaction on Monday, November 24th. The stock was sold at an average price of $74.10, for a total transaction of $12,319,125.00. Following the sale, the chief executive officer directly owned 9,008,033 shares of the company’s stock, valued at $667,495,245.30. This represents a 1.81% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 600,332 shares of company stock worth $41,554,949 in the last 90 days. 26.27% of the stock is currently owned by corporate insiders.

Tempus AI Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.